{"id":1423,"date":"2025-11-29T12:54:17","date_gmt":"2025-11-29T12:54:17","guid":{"rendered":"https:\/\/snips.nutrifytoday.com\/blog\/?p=1423"},"modified":"2025-11-29T12:54:17","modified_gmt":"2025-11-29T12:54:17","slug":"arginine-emerges-as-a-promising-low-cost-candidate-in-alzheimers-research","status":"publish","type":"post","link":"https:\/\/snips.nutrifytoday.com\/blog\/arginine-emerges-as-a-promising-low-cost-candidate-in-alzheimers-research\/","title":{"rendered":"Arginine Emerges as a Promising Low-Cost Candidate in Alzheimer\u2019s Research"},"content":{"rendered":"\n<p>A new study published in Neurochemistry International unveils a breakthrough in the search for safer and more accessible Alzheimer\u2019s disease (AD) treatments. Researchers from Kindai University report that oral arginine\u2014a naturally occurring amino acid\u2014can effectively suppress amyloid \u03b2 (A\u03b2) aggregation, a key driver of AD pathology. While current antibody-based therapies target A\u03b2, their limited effectiveness, high cost, and immune-related side effects highlight the urgent need for alternatives. In both Drosophila and mouse models of AD, arginine significantly reduced amyloid plaque burden, lowered insoluble A\u03b242 levels, and improved behavioral outcomes. The treatment also dampened neuroinflammation, suggesting broader neuroprotective effects beyond aggregation control. Because arginine is clinically safe, inexpensive, and readily available, researchers propose it as a strong candidate for drug repositioning.<\/p>\n\n\n\n<p>Source : <a href=\"https:\/\/www.sciencedirect.com\/science\/article\/pii\/S019701862500155X?via%3Dihub\">https:\/\/www.sciencedirect.com\/science\/article\/pii\/S019701862500155X?via%3Dihub<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new study published in Neurochemistry International unveils a breakthrough in the search for safer and more accessible Alzheimer\u2019s disease (AD) treatments. Researchers from Kindai University report that oral arginine\u2014a naturally occurring amino acid\u2014can effectively suppress amyloid \u03b2 (A\u03b2) aggregation, a key driver of AD pathology. While current antibody-based therapies target A\u03b2, their limited effectiveness, [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1423","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/comments?post=1423"}],"version-history":[{"count":1,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1423\/revisions"}],"predecessor-version":[{"id":1424,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/posts\/1423\/revisions\/1424"}],"wp:attachment":[{"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/media?parent=1423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/categories?post=1423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/snips.nutrifytoday.com\/blog\/wp-json\/wp\/v2\/tags?post=1423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}